November 5, 2021
What You Lose with Automation
Brandon Salke, Pharmacist in Charge, General Manager of Operations, Optime Care “Thank you for calling…
Read More
April 13, 2021
Optime Care Featured in Mergermarket Publication for Advisory, Corporate and Financial Communities
Donovan Quill, President and CEO, Optime Care, interview featured on April 5, 2021: Mergermarket There…
Read More
July 7, 2020
Rare Voices S1E2: Jim Clement, Coeus Consulting
One of the least understood components of commercialization is the role of the payer. For…
Read More 
June 18, 2020
Revealing 5 hidden truths about using a hub-and-spoke model for rare and orphan drugs
The hub-and-spoke approach has become a standard of drug commercialization. Having a network of patient…
Read More
June 16, 2020
Debunking 6 Myths About Gaining Payer Access for Rare and Orphan Drugs
What works for large patient populations isn’t necessarily a good fit for those with rare…
Read More
